P29 Treating hepatitis C virus infection (HCV) with direct acting antivirals (DAAs) through the existing infrastructure of opioid agonist therapy (OAT)

• J. Keats,
• S. Hazelwood,
• C. Cochrane,
• G. Laker,
• E. George,
• A.D. Dunlop

Affiliations

J. Keats

Hunter New England Local Health District Drug and Alcohol Clinical Services, Australia

S. Hazelwood

Hunter New England Local Health District Drug and Alcohol Clinical Services, Australia

C. Cochrane

Hunter New England Local Health District Drug and Alcohol Clinical Services, Australia

G. Laker

Hunter New England Local Health District Drug and Alcohol Clinical Services, Australia

E. George

Drug and Alcohol Health Services Inc (Muswellbrook), Australia

A.D. Dunlop

Hunter New England Local Health District Drug and Alcohol Clinical Services, Australia; University of Newcastle, Australia